23andMe
Genomics/digital healthUSA
New to Unitard
π Dead / Bankrupt
PeakΒ $6 BillionToday
~-99%
from peak
- π¦Became a unicorn~2015
- πPeak valuation$6 Billion β21
- πBecame a UnitardMar 2025
- πΈLast valuationWiped out
π₯ Raised & burned
$944M
Total raised
$138K/day
Burned Β· 18.7y alive
Funding: Tracxn/Crunchbase
Current status
Bankrupt March 2025; assets to TTAM (Wojcicki) $305M, closed July 2025
The rise & fall
9 moments Β· 2006β2025The key moments, with employee sentiment along the way.
2006
2006
Founded by Anne Wojcicki
Consumer DNA kits promise ancestry and health insights from a tube of spit.
Wikipedia
2015
2015
Joins the unicorn club
A funding round values the genetics pioneer above $1B.
Fortune
Jun 2021
Jun 2021
The peak: a Branson SPAC listing$6B
Goes public via VG Acquisition at a valuation around $6B.
CNBC
Oct 2023
Oct 2023
The data breach
Hackers access profile data tied to roughly 6.9M users; trust β the product β takes the hit.
Reuters
2021β24
From the inside Β· Glassdoor reviews, 2021β24
Glassdoor reviews traced the decline from inside: near-annual layoffs and benefit cuts after the SPAC listing, and a business insiders said never found a path to profitability.
Sep 2024
Sep 2024
The independent board resigns en masse
Directors quit over Wojcicki's take-private plans; the stock flirts with delisting.
WSJ
Mar 2025
Mar 2025
Chapter 11 β joins the Unitard Club π
Wojcicki resigns as CEO; 15M customers' DNA becomes the bankruptcy's most contested asset.
Court filing
Jul 2025
Jul 2025
Wojcicki's nonprofit buys it back
TTAM outbids Regeneron with $305M for the assets.
Reuters
$5.94Bof peak value erased Β· 19 years
π¬ entries paraphrase anonymous, unverified reviews posted publicly on Glassdoor β; dated facts carry their source.
How it happened
23andMe pioneered consumer DNA testing and went public via SPAC in 2021 at a valuation around $6B. A failure to build a sustainable business beyond one-time test kits, a 2023 data breach, and dwindling cash crushed it. It filed for Chapter 11 in March 2025, and co-founder Anne Wojcicki's nonprofit TTAM bought the assets for $305M that July.
Source: Outbid Regeneron; SEC deregistration June 2025
